The Role of Astroglial-NF--kB in SCI
The Role of Astroglial-NF--kB in SCI
批准号:
8460533
负责人:
John Roland Bethea
金额:
$30.51万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2013-12-31
关键词:
2&apos,3&apos-Cyclic-Nucleotide PhosphodiesterasesAMPA ReceptorsAstrocytesCCL2 geneCD8B1 geneCXCL10 geneCXCL12 geneCXCR4 ReceptorsCXCR4 geneCellsCentral Nervous System DiseasesCessation of lifeComplementComplexDataDemyelinationsDiseaseEngineeringEnvironmentFlow CytometryFunctional disorderGene ProteinsGlial Fibrillary Acidic ProteinGlutamatesGoalsImmuneIn VitroInflammationInflammatoryInjuryLaboratoriesLeadLeukocytesMediatingMultiple SclerosisMusMyelinNADPH OxidaseNF-kappa BNeuritesNeurodegenerative DisordersNeuronsOligodendrogliaPathway interactionsPlayRecovery of FunctionRelative (related person)ResearchReverse Transcriptase Polymerase Chain ReactionRoleSpinal CordSpinal cord injuryStromal Cell-Derived Factor 1T-LymphocyteTLR4 geneTNF geneTestingTherapeuticTransgenic MiceWestern Blottingbasecell typecentral nervous system injurychemokinecytokinedesignexcitotoxicityimprovedin vivoin vivo Modelinhibitor/antagonistinjuredmacrophagemouse modelmyelinationnervous system disordernovelprogramsprotein expressionpublic health relevancereceptorremyelinationresponsetherapy developmenttranscription factorwhite matterwhite matter damage
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our research program investigates the role of astrocytes and in particular astroglial- NF?B in the pathophysiology of neurodegenerative disorders. The experimental aims proposed in this application will test two objectives and are based upon extensive preliminary data. In support of our first objective we have determined there is a significant reduction in oligodendrocyte death, oxidative injury and NADPH oxidase activity following injury. Furthermore, based upon completed and partially confirmed micro array studies, preliminary flow cytometry and immunostaining we have determined that inhibiting astroglial- NF?B greatly modifies the inflammatory environment in the spinal cord such that potentially toxic immunoregulatory molecules along with infiltrating leukocytes are significantly altered in injured TG mice relative to injured WT mice. With respect to the first objective we hypothesize that astrocyte mediated oligodendrocyte death is dependent upon engineering a robust inflammatory environment as well as complex interactions between oxidative pathways and excitotoxicity. In support of our second objective we have significant preliminary data that are very supportive of enhanced oligogenesis. First, we demonstrate there is significantly more white matter in our TG mice following SCI which could be due to reduced oligodendrocyte death (objective 1) and /or oligogenesis. We have also demonstrated there is enhanced myelin gene/protein expression in TG mice following injury, as well as transcription factors known to be important in oligogenesis. Finally it has been previously demonstrated that CXCL12 (SDF-1) and its receptors (CXCR4 and CXCR7) support oligogenesis and neurite extension on inhibitory substrates. Results from completed microarray studies that have been confirmed by quantitative RT-PCR and Western blotting have determined that specific immune/inflammatory molecules such as chemokines and their receptors (e.g., CXCL12 and CXCR4) are elevated in TG mice following SCI during periods of oligogenesis/remyelination and functional recovery. With respect to our second objective we hypothesize that inhibiting astroglial- NF?B promotes an environment that is favorable for oligogenesis and remyelination. These hypotheses and our experimental objectives will be tested in the following specific aims. Specific Aim 1: Investigate the role of oxidative injury in astrocyte mediated oligodendrocyte death and demyelination. Specific Aim 2: Investigate the role of inflammation in astrocyte mediated oligodendrocyte death and demyelination. Specific Aim 3: Determine what effect inhibiting astroglial- NF?B has on oligogenesis and remyelination following SCI. Specific Aim 4: Investigate the role of CXCL12 and CXCR4 in oligogenesis and remyelination following SCI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TNFR2 Sex Differences and EAE
-
批准号:10384115
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2021
-
负责人:John Roland Bethea
-
依托单位:
TNFR2 Sex Differences and EAE
-
批准号:10532717
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2021
-
负责人:John Roland Bethea
-
依托单位:
SCI-induced deficits in antiviral immunity: The role of sTNF.
-
批准号:10207806
-
项目类别:
-
资助金额:$49.2万
-
财政年份:2019
-
负责人:John Roland Bethea
-
依托单位:
SCI-induced deficits in antiviral immunity: The role of sTNF.
-
批准号:10019418
-
项目类别:
-
资助金额:$49.2万
-
财政年份:2019
-
负责人:John Roland Bethea
-
依托单位:
SCI-induced deficits in antiviral immunity: The role of sTNF.
-
批准号:10441446
-
项目类别:
-
资助金额:$49.2万
-
财政年份:2019
-
负责人:John Roland Bethea
-
依托单位:
SCI-induced deficits in antiviral immunity: The role of sTNF.
-
批准号:10657427
-
项目类别:
-
资助金额:$49.2万
-
财政年份:2019
-
负责人:John Roland Bethea
-
依托单位:
Soluble TNFa in the development of autonomic dysreflexia after spinal cord injury
-
批准号:10386794
-
项目类别:
-
资助金额:$55.06万
-
财政年份:2018
-
负责人:John Roland Bethea
-
依托单位:
Soluble TNFa in the development of autonomic dysreflexia after spinal cord injury
-
批准号:9902562
-
项目类别:
-
资助金额:$57.09万
-
财政年份:2018
-
负责人:John Roland Bethea
-
依托单位:
Enhancing supraspinal plasticity to improve functional recovery after SCI
-
批准号:9976601
-
项目类别:
-
资助金额:$59.57万
-
财政年份:2017
-
负责人:John Roland Bethea
-
依托单位:
Enhancing supraspinal plasticity to improve functional recovery after SCI
-
批准号:9193741
-
项目类别:
-
资助金额:$60.21万
-
财政年份:2016
-
负责人:John Roland Bethea
-
依托单位:
Astrocytes Play a Critical Role in the Pathology of EAE
-
批准号:8824782
-
项目类别:
-
资助金额:$8.33万
-
财政年份:2009
-
负责人:John Roland Bethea
-
依托单位:
Astrocytes Play a Critical Role in the Pathology of EAE
-
批准号:8063946
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2009
-
负责人:John Roland Bethea
-
依托单位:
Astrocytes Play a Critical Role in the Pathology of EAE
-
批准号:8462700
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2009
-
负责人:John Roland Bethea
-
依托单位:
Astrocytes Play a Critical Role in the Pathology of EAE
-
批准号:7743678
-
项目类别:
-
资助金额:$32.91万
-
财政年份:2009
-
负责人:John Roland Bethea
-
依托单位:
Astrocytes Play a Critical Role in the Pathology of EAE
-
批准号:8259198
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2009
-
负责人:John Roland Bethea
-
依托单位:
The Role of Astroglial-NF-kB in SCI
-
批准号:6914116
-
项目类别:
-
资助金额:$35.03万
-
财政年份:2005
-
负责人:John Roland Bethea
-
依托单位:
The Role of Astroglial-NF-kB in SCI
-
批准号:7176070
-
项目类别:
-
资助金额:$33.22万
-
财政年份:2005
-
负责人:John Roland Bethea
-
依托单位:
The Role of Astroglial-NF-kB in SCI
-
批准号:7566013
-
项目类别:
-
资助金额:$33.22万
-
财政年份:2005
-
负责人:John Roland Bethea
-
依托单位:
The Role of Astroglial-NF-kB in SCI
-
批准号:7017095
-
项目类别:
-
资助金额:$34.21万
-
财政年份:2005
-
负责人:John Roland Bethea
-
依托单位:
The Role of Astroglial-NF--kB in SCI
-
批准号:8662321
-
项目类别:
-
资助金额:$44.23万
-
财政年份:2005
-
负责人:John Roland Bethea
-
依托单位: